DRKS00004658已完成2 期
Therapy of polycythemia vera with pegylated interferon - PV-PegIntron-Study
III. Medizinische Universitätsklinik Universitätsmedizin Mannheim0 个研究点目标入组 47 人开始时间: 2013年1月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 47
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Diagnosis PV according to the WHO criteria,
- •age 18 years or older without upper age limit,
- •no cytoreductive pretreatment or pretreatment with at most one cytoreductive drug,
- •persistent need of phlebotomies during previous therapy
- •no preteatment with non-pegylated interferon alpha,
- •written informed consent.
排除标准
- •Cytoreductive pretreatment with more than one drug,
- •pretreatment with non-pegylated interferon alpha
- •postpolycythemic myelofibrosis,
- •splenectomy,
- •secondary malignancy, if requiring therapy
- •severe comorbidity,
- •pregnancy and breast feeding,
- •diseases of CNS
- •psychiatric disorders,
- •paticipation in an other cliniocal study,
- •no consent of the patient.
研究者
相似试验
暂停
不适用
Patient-specific treatment of Polycythemiavera using a model of erythropoiesisD45Polycythaemia veraDRKS00011060niversitätsklinikum Magdeburg A.ö.R.Universitätsklinik für Hämatologie und Onkologie20
招募中
不适用
Effect of combination therapy of Pegylated interferon- Alpha 2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks on viral loads in HCV Genotype 3 chronic hepatitis & compensated cirrhosis patientsHCV genotype 3 related chronic hepatitis & compensated cirrhosisSLCTR/2017/007Department of Hepatology Bangabandhu Sheikh Mujib Medical University
已完成
不适用
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot StructureThrombocythemia, EssentialPolycythemia VeraNCT02912884Dr Yan Beauverd80
已完成
不适用
Combination therapy using pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C virus (HCV) infection 3 to 120 months after liver transplantatioHepatitis C reinfection after liver transplantationInfections and InfestationsChronic viral hepatitisISRCTN51477478Hannover Medical School (Medizinische Hochschule Hannover) (Germany)75
已完成
不适用
sefulness of Add-on Therapy of Pegylated Interferon alfa2a with Nucleoside/nucleotide Analog Treatment for Patients with Hepatitis B Virus InfectioChronic Hepatitis BJPRN-UMIN000032717Saitama Medical University, Department of Gastroenterology & Hepatology26